We demonstrated that with a two-week insulin infusion, myoblasts from IUGR-I fetuses increased the percentage of cells in the S/G2/M cell cycle stages when compared to both IUGR-S and CON-S fetuses. The gene discussed is INS; the disease is fetal growth restriction.